A direct consequence of these properties is that the glucocorticoid-activated GR can attenuate the biological actions of androgen-activated AR genes, suggesting an AR-dependent mechanism where GR can actually function as a tumour suppressor in cases of prostate cancer [97,98]. This evidence concerns the gene NR3C1 and Familial prostate cancer.